RXST
RxSight, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.51
−3.43%Price chart
Sep 17Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16
Key dataOct 16, 2026
Open$4.76
From 52W high−65.55%
Volume1.03M
Market cap$187.59M
P/E (TTM)—
P/S (TTM)1.5x
Div yield—
Key dataOct 16, 2026
Open
$4.76
From 52W high
−65.55%
Volume
1.03M
Market cap
$187.59M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.2x
P/E (TTM)
—
RSI (14)
36.9
MomentumView details →
1D Return
−3.43%
YTD Return
−55.47%
SummaryUpdated Jun 1, 2026
RxSight, Inc. (NASDAQ:RXST) is a medical technology company founded in 1997 and headquartered in Aliso Viejo, California. Originally incorporated as Calhoun Vision, Inc., the company changed its name to RxSight in February 2017 and went public in July 2021. RxSight has developed and commercialized the world's first and only adjustable intraocular lens technology for cataract surgery, allowing surgeons to customize patients' vision after the initial surgical procedure. The company primarily serves the United States market with plans for international expansion into Europe and Asia.
Similar companies
Latest newsMore news →
K2 Vision reported performing more than 5,000 Light Adjustable Lens procedures and said RxSight, Inc. recognized it as the world's highest-volume Light Adjustable Lens practice.4h agoRxSight, Inc. reported a second-quarter loss of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.21, and compared to a loss of $0.08 per share a year ago.72d ago